endorectal brachytherapy

RADIATION2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, University Hospital, Bordeaux

Conditions

Locally Advanced Rectal CarcinomaRectal or Anal Cancer

Phase 1

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

CompletedNCT02199236

Memorial Sloan Kettering Cancer CenterRectal or Anal Cancer

Start: 2014-07-31End: 2024-10-29Updated: 2024-11-01

Phase 2

Endorectal Brachytherapy for Rectal Cancer

SuspendedNCT05591534

University Hospital, BordeauxLocally Advanced Rectal Carcinoma

Start: 2024-01-31End: 2027-01-31Target: 31Updated: 2025-08-01